Active Parkinson Disease Protein 7 (PARK7)

DJ1; Autosomal Recessive,Early Onset

ACTIVITY TEST

Parkinson Disease Protein 7 (PARK7), a small multifunctional protein (20 kDa) containing 189 amino acids, which participates in transcriptional regulation  and mitochondrial regulation, and acts as a molecular chaperone, oxidative stress sensor, and glyoxalase. It has also been described as a protein and nucleotide deglycase. Mutations in Park7 are associated with a small percentage of hereditary early onset Parkinson’s disease. Leucine Rich Repeat Kinase 2 (LRRK2) has been identified as an interactor of PARK7, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human PARK7 and recombinant human LRRK2. Briefly, PARK7 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to LRRK2-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-PARK7 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630 nm immediately. The binding activity of recombinant human PARK7 and recombinant human LRRK2 was shown in Figure 1, the EC50 for this effect is 0.16 ug/mL.

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPL059Hu02 Recombinant Parkinson Disease Protein 7 (PARK7) Positive Control; Immunogen; SDS-PAGE; WB.
RPL059Hu01 Recombinant Parkinson Disease Protein 7 (PARK7) Positive Control; Immunogen; SDS-PAGE; WB.
APL059Hu01 Active Parkinson Disease Protein 7 (PARK7) Cell culture; Activity Assays.
PAL059Hu02 Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) WB; IHC; ICC; IP.
PAL059Hu01 Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) WB,IHC
LAL059Hu71 Biotin-Linked Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) WB; IHC; ICC.
LAL059Hu81 FITC-Linked Polyclonal Antibody to Parkinson Disease Protein 7 (PARK7) WB; IHC; ICC; IF.
MAL059Hu22 Monoclonal Antibody to Parkinson Disease Protein 7 (PARK7) WB; IHC; ICC; IP.
MAL059Hu21 Monoclonal Antibody to Parkinson Disease Protein 7 (PARK7) WB; IHC; ICC; IP.
MAL059Hu23 Monoclonal Antibody to Parkinson Disease Protein 7 (PARK7) WB; IHC; ICC; IP.
SEL059Hu ELISA Kit for Parkinson Disease Protein 7 (PARK7) Enzyme-linked immunosorbent assay for Antigen Detection.
HEL059Hu High Sensitive ELISA Kit for Parkinson Disease Protein 7 (PARK7) Enzyme-linked immunosorbent assay for Antigen Detection.
LML059Hu Multiplex Assay Kit for Parkinson Disease Protein 7 (PARK7) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.